| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5623055 | Alzheimer's & Dementia | 2013 | 7 Pages |
Abstract
Treatment with RASB might modulate serum adipocytokines and glucose homeostasis, potentially slowing cognitive decline in patients with AD.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Yoshiko Furiya, Miwa Ryo, Makoto Kawahara, Takao Kiriyama, Masami Morikawa, Satoshi Ueno,